Microbiome plays Second Genome, Enterome raise funds

Second Genome Inc. (South San Francisco, Calif.) and Enterome Bioscience S.A. (Paris, France) each raised venture rounds on Wednesday.

Second Genome raised $42.6 million in a series B round co-led by new investors Pfizer Venture Investments and Roche Venture Fund. New investors Digitalis Ventures, Adveq, LifeForce Capital, MBL Venture Capital and Mayo Clinic also participated, as did existing investors Advanced Technology Ventures, Morgenthaler Ventures, Seraph Group and individual investor Matthew Winkler. ...